In the era of precision medicine, targeting the mutations driving cancer growth, rather than the tumor site itself, continues to be a successful approach for some patients. In the latest example, researchers from Penn Medicine ...
8 hours ago
Nottingham scientists have identified a new breast cancer gene which, when over-expressed or mutated, indicates which patients will benefit from chemotherapy.
Jun 30, 2016